ClinVar Miner

Submissions for variant NM_004959.5(NR5A1):c.938G>A (p.Arg313His)

dbSNP: rs1554721235
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000521048 SCV000617598 pathogenic not provided 2019-12-24 criteria provided, single submitter clinical testing Published functional studies demonstrate that this variant results in impaired transactivation activity and structural alteration at functional domains (Perez Garrido et al., 2015); Not observed in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Reported previously in association with severe hypospadias and variable micropenis and cryptorchidism in at least one family, affected males inherited the variant from their unaffected father (Adamovic et al., 2012); This variant is associated with the following publications: (PMID: 25160005, 23154282, 22907560, 22100173, 30425642)
Revvity Omics, Revvity RCV000521048 SCV002020160 likely pathogenic not provided 2021-11-01 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV002527576 SCV003441482 pathogenic Oligosynaptic infertility; 46,XY disorder of sex development 2021-12-27 criteria provided, single submitter clinical testing This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 313 of the NR5A1 protein (p.Arg313His). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with NR5A1-related conditions (PMID: 22907560, 30425642). In at least one individual the variant was observed to be de novo. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 449434). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. This variant disrupts the p.Arg313 amino acid residue in NR5A1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 22028768, 25122490, 27169744, 30425642). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.
Center for Reproductive Medicine, Shandong Provincial Hospital Affiliated to Shandong University RCV001662528 SCV001877167 pathogenic Genetic non-acquired premature ovarian failure 2019-10-01 no assertion criteria provided research

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.